Ensign Peak Advisors’s Vaxcyte PCVX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $17.3M | Sell |
|
|||||
|
2025
Q1 | $28.1M | Buy |
|
|||||
|
2024
Q4 | $48M | Buy |
|
|||||
|
2024
Q3 | $62.5M | Buy |
|
|||||
|
2024
Q2 | $34.9M | Sell |
|
|||||
|
2024
Q1 | $32.5M | Buy |
|
|||||
|
2023
Q4 | $22.7M | Buy |
|
|||||
|
2023
Q3 | $14.1M | Hold |
|
|||||
|
2023
Q2 | $13.8M | Buy |
|
|||||
|
2023
Q1 | $9.33M | Buy |
|
|||||
|
2022
Q4 | $11.9M | Buy |
|
|||||
|
2022
Q3 | $2.49M | Buy |
|
|||||
|
2022
Q2 | $1.63M | Buy |
|
|||||
|
2022
Q1 | $867K | Buy |
|
|||||
|
2021
Q4 | $34K | Buy |
|
|||||
|
2021
Q2 | – | Sell |
|
|||||
|
2021
Q1 | $412K | Hold |
|
|||||
|
2020
Q4 | $555K | Buy |
|